METTL3-dependent m6A modification of SNAP29 induces "autophagy-mitochondrial crisis" in the ischemic microenvironment

Ningning Yang1,2,3, Yingying Lai1,2,4, Gaoxiang Yu1,2,4

  • 1Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.

Autophagy
|May 9, 2025
PubMed

Insights

Restoring synaptosomal-associated protein 29 (SNAP29) in ischemic flaps prevents necrosis by reversing the autophagy-mitochondrial crisis. This involves inhibiting METTL3-mediated m6A methylation to restore autophagic flux and reduce parthanatos.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Regenerative Medicine

Background:

  • Ischemic flap necrosis increases patient pain and healthcare costs.
  • Mechanisms linking disrupted autophagy to parthanatos in ischemic flaps are unclear.
  • Reactive oxygen species (ROS) and mitochondrial damage contribute to parthanatos.

Purpose of the Study:

  • To investigate the role of SNAP29 in ischemic flap necrosis.
  • To elucidate the link between disrupted autophagic flux, m6A methylation, and parthanatos.
  • To identify therapeutic targets for promoting ischemic flap survival.

Main Methods:

  • Western blotting, immunofluorescence staining, and proteomic analysis identified SNAP29 deficiency.
  • Adeno-associated virus (AAV) vector was used to restore SNAP29 in vivo.
  • RNA immunoprecipitation (RIP-qPCR), methylated RNA immunoprecipitation (MeRIP-qPCR), and RNA stability assays assessed m6A methylation of Snap29 mRNA.
  • In vitro and in vivo experiments verified METTL3's role in SNAP29 depletion and autophagic flux disruption.

Main Results:

  • SNAP29 deficiency in ischemic flaps disrupted autophagic flux, increased ROS-induced parthanatos, and aggravated necrosis.
  • In vivo SNAP29 restoration via AAV mitigated autophagic flux disruption and parthanatos.
  • METTL3-mediated m6A methylation of Snap29 mRNA promoted its depletion and disrupted autophagic flux.
  • Inhibiting METTL3 and YTHDF2 restored SNAP29, reversed the 'autophagy-mitochondrial crisis', and promoted flap survival.

Conclusions:

  • SNAP29 deficiency is a key driver of ischemic flap necrosis via the autophagy-mitochondrial crisis.
  • METTL3-mediated m6A methylation of Snap29 mRNA is a critical regulatory mechanism.
  • Targeting METTL3 and YTHDF2 to restore SNAP29 presents a promising therapeutic strategy for ischemic flap survival.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.3K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.7K
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
3.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
4.9K
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
4.9K